E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 

Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each.


Click on the deal summary to see the full details.

Apidos CLO XXII/Apidos CLO XXII LLC L+106 due April 2031

Apidos CLO XXII/Apidos CLO XXII LLC L+150 due April 2031

Apidos CLO XXII/Apidos CLO XXII LLC L+195 due April 2031

Apidos CLO XXII/Apidos CLO XXII LLC L+295 due April 2031

Apidos CLO XXII/Apidos CLO XXII LLC L+675 due April 2031

Apidos CLO XXII/Apidos CLO XXII LLC L+865 due April 2031

Apidos CLO XXII/Apidos CLO XXII LLC due April 2031

Apidos CLO XXII/Apidos CLO XXII LLC L+100 due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC L+150 due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC L+205 due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC 4.040% due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC L+275 due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC L+380 due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC L+600 due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC L+725 due 10/20/2027

Apidos CLO XXII/Apidos CLO XXII LLC due 10/20/2027



© 2012 Prospect News.
All content in this database is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.